Pancreatic beta cell insulin secretion pathway

The pancreatic beta cell insulin secretion pathway refers to a tightly regulated, multi-step process by which pancreatic beta cells sense changes in blood glucose levels and secrete insulin accordingly. The pathway is initiated when glucose enters beta cells via GLUT transporters, is metabolized to raise the intracellular ATP/ADP ratio, leading to closure of ATP-sensitive potassium (KATP) channels. This causes cell membrane depolarization, opening voltage-gated calcium channels and allowing calcium influx, which triggers exocytosis of insulin-containing granules. The pathway also involves amplification by other fuel stimuli, hormonal regulation (e.g., via GLP-1), and is a critical determinant of glucose homeostasis. Dysfunction or failure of this pathway results in diabetes and is the mechanistic target of several diabetes therapies.

Other names

Glucose-stimulated insulin secretion pathwayGSIS pathwayPancreatic beta-cell signaling pathwayInsulin exocytosis pathway

Varies by the molecular target within the pathway; examples include: KATP channel inhibition to trigger insulin secretion (sulfonylureas); GLP-1 receptor activation to amplify glucose-dependent insulin release; DPP-4 inhibition to sustain GLP-1 activity. Generally, mechanisms aim to increase or potentiate insulin secretion by modulating nutrient sensing, second messengers, or exocytosis machinery within beta cells.